Aslan Pharmaceuticals Ltd ADR (ASLN) Annual Income Statement (USD)
ASLN Quarterly Financials (USD)
Frequently Asked Questions About Aslan Pharmaceuticals Ltd ADR (ASLN) Stock
Aslan Pharmaceuticals Ltd ADR's (ASLN) last reported annual revenue was USD 12.00 Million.
Aslan Pharmaceuticals Ltd ADR's (ASLN) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Aslan Pharmaceuticals Ltd ADR's(ASLN) is not profitable as of its last reported annual financials.
The net profit margin for Aslan Pharmaceuticals Ltd ADR's(ASLN) from its laster reported year is -368.50%
The return on equity (ROE) for Aslan Pharmaceuticals Ltd ADR's(ASLN) from its last reported annual financials is : -426.64%
The return on assets (ROA) for Aslan Pharmaceuticals Ltd ADR's(ASLN) from its last reported annual financials is : -63.71%
The return on invested capital (ROIC) for Aslan Pharmaceuticals Ltd ADR's(ASLN) from its last reported annual financials is : -148.50%
The Debt to Equity ratio for Aslan Pharmaceuticals Ltd ADR's(ASLN) from its last reported annual financials is : -186.64%
The dividend yield for Aslan Pharmaceuticals Ltd ADR's(ASLN) from its laster reported year is 0.00%
Aslan Pharmaceuticals Ltd ADR's(ASLN) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ASLN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
